UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer

Journal of clinical oncology, 2005-06, Vol.23 (17), p.3923-3931

2005

Volltextzugriff (PDF)

Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma

Journal of clinical oncology, 2009-06, Vol.27 (18), p.3007-3013

2009

Volltextzugriff (PDF)

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2004-03, Vol.22 (6), p.1103-1109

2004

Volltextzugriff (PDF)

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma

Journal of clinical oncology, 2016-08, Vol.34 (23), p.2761-2768

2016

Volltextzugriff (PDF)

Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm—Combined Prospective Analysis by the German AML Intergroup

Journal of clinical oncology, 2012-10, Vol.30 (29), p.3604-3610

2012

Volltextzugriff (PDF)

Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis

Journal of clinical oncology, 2014-02, Vol.32 (4), p.288-296

2014

Volltextzugriff (PDF)

Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.8519-8519

2016

Volltextzugriff (PDF)

Pilot Trial of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib Plus Carboplatin and Paclitaxel in Patients With Stage IIIB or IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2003-06, Vol.21 (11), p.2094-2100

2003

Volltextzugriff (PDF)

Phase II Trial of Docetaxel and Vinorelbine in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1346-1350

2000

Volltextzugriff (PDF)

Confirmation of high prevalence of BAP1 inactivation in mesothelioma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.7564-7564

2015

Volltextzugriff (PDF)

Phase I study of intra-pleural administration of GL-ONC1, an oncolytic vaccinia virus, in patients with malignant pleural effusion

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.7559-7559

2015

Volltextzugriff (PDF)

Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine: A Pan-European study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e15774-e15774

2017

Volltextzugriff (PDF)

Clinical characteristics of patients with malignant pleural mesothelioma (MPM) harboring somatic BAP1 mutations

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.1541-1541

2012

Volltextzugriff (PDF)

A multicenter phase II toxicity study of lung-sparing intensity modulated radiation therapy (IMRT) for malignant pleural mesothelioma (MPM)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7581-7581

2014

Volltextzugriff (PDF)

Are there differences in chemotherapy (CT) administration and outcomes in elderly patients diagnosed with colorectal cancer (CRC)?

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e19521-e19521

2011

Volltextzugriff (PDF)

Prevalence of germline BAP1 mutations in patients with malignant mesothelioma (MM)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e18542-e18542

2014

Volltextzugriff (PDF)

Are there differences in chemotherapy (CT) administration and outcomes in elderly patients (pts) diagnosed with colorectal cancer (CRC)?

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.557-557

2011

Volltextzugriff (PDF)

Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS139-TPS139

2011

Volltextzugriff (PDF)

Phase II study of ADI-PEG 20 in patients with relapsed sensitive or refractory small cell lung cancer

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e17558-e17558

2012

Volltextzugriff (PDF)

Quantitating pathologic response to neoadjuvant chemotherapy in KRAS -mutated versus nonmutated lung cancers

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.7014-7014

2012

Volltextzugriff (PDF)

High-dose chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor- and intermediate-prognosis metastatic germ cell tumors: A retrospective monocenter analysis of 44 cases

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e15043-e15043

2011

Volltextzugriff (PDF)

A randomized phase III study of elacytarabine versus limited investigator’s choice in patients with refractory acute myeloid leukemia (AML)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.TPS206-TPS206

2011

Volltextzugriff (PDF)

Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7557-7557

2010

Volltextzugriff (PDF)

A multicenter U.S. trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and hemithoracic radiation (RT) for stage I-III malignant pleural mesothelioma (MPM)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.7561-7561

2007

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

ThemaPhysics

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Oncology
(11)
Adult
(9)
Female
(9)
Humans
(9)
Life Sciences & Biomedicine
(9)
Male
(9)
Middle Aged
(9)
Science & Technology
(9)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Aged
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Tumors
(5)
Prospective Studies
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(3)
Disease-Free Survival
(3)
Kaplan-Meier Estimate
(3)
Lung Neoplasms - Drug Therapy
(3)
Treatment Outcome
(3)
Adolescent
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(36)
Journals@Ovid Ovid Full Text
(36)
Single Journals
(36)
IngentaConnect Journals
(13)
IngentaConnect
(13)
MEDLINE
(9)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer

Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma

Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm—Combined Prospective Analysis by the German AML Intergroup

Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis

Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial

Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy

Pilot Trial of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib Plus Carboplatin and Paclitaxel in Patients With Stage IIIB or IV Non–Small-Cell Lung Cancer

Phase II Trial of Docetaxel and Vinorelbine in Patients With Advanced Non–Small-Cell Lung Cancer

Confirmation of high prevalence of BAP1 inactivation in mesothelioma

Phase I study of intra-pleural administration of GL-ONC1, an oncolytic vaccinia virus, in patients with malignant pleural effusion

Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine: A Pan-European study

Clinical characteristics of patients with malignant pleural mesothelioma (MPM) harboring somatic BAP1 mutations

A multicenter phase II toxicity study of lung-sparing intensity modulated radiation therapy (IMRT) for malignant pleural mesothelioma (MPM)

Are there differences in chemotherapy (CT) administration and outcomes in elderly patients diagnosed with colorectal cancer (CRC)?

Prevalence of germline BAP1 mutations in patients with malignant mesothelioma (MM)

Are there differences in chemotherapy (CT) administration and outcomes in elderly patients (pts) diagnosed with colorectal cancer (CRC)?

Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)

Phase II study of ADI-PEG 20 in patients with relapsed sensitive or refractory small cell lung cancer

Quantitating pathologic response to neoadjuvant chemotherapy in KRAS -mutated versus nonmutated lung cancers

High-dose chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor- and intermediate-prognosis metastatic germ cell tumors: A retrospective monocenter analysis of 44 cases

A randomized phase III study of elacytarabine versus limited investigator’s choice in patients with refractory acute myeloid leukemia (AML)

Phase II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

A multicenter U.S. trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and hemithoracic radiation (RT) for stage I-III malignant pleural mesothelioma (MPM)

Aktive Filter

Suchergebnisse filtern